IRCT20200428047232N1已完成3 期
Effectiveness and safety of thalidomide in moderate COVID-19 pneumonia: A randomized clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •18-75 year old men and 50-75 year old women admitted in hospital
- •Percentage of oxygen saturation at the time of admission: 89-85% (provided it is modified with Nazal auxiliary oxygen to more or equal to 90%) or oxygen saturation percentage of 90-93% and the number of breaths per minute more or equal to 30
- •Clinical manifestations associated with COVID-19 pneumonia with positive PCR test or HR-CT scan
排除标准
- •Previous Chronic lung disease
- •Multi-organ failure at admission
研究者
相似试验
尚未招募
3 期
ââ?¬Å?To compare the Effectiveness and Safety between Thalidomide and Azathioprine in type two lepra reaction: A Randomized Controlled Trialââ?¬?CTRI/2022/09/045482Deepak Kumar Sahu
尚未招募
2 期
OW DOSE THALIDOMIDE VERSUS HYDROXYUREA IN TRANSFUSION DEPENDENT THALASSEMIA PATIENTSCTRI/2020/05/025142ALKA RANI KHADWA
进行中（未招募）
1 期
Efficacy of thalidomide in the treatment of heavy and frequent nose bleeding in patients affected by hereditary hemorrhagic telangiectasiaSevere recurrent epistaxis in hereditary hemorrhagic telangiectasiaMedDRA version: 14.1Level: LLTClassification code 10038554Term: Rendu-Osler-Weber syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2011-004096-36-ITOSPEDALE POLICLINICO S. MATTEO31
尚未招募
3 期
se of medicines- Hydroxyurea and thalidomide for children suffering from thalassemiaCTRI/2023/12/060945ICMR, Delhi
进行中（未招募）
1 期
Phase II study of thalidomide in combination with temozolomide in metastatic malignant melanoma with brain metastases - Tem-ThalAdvanced metastic malignant melanomaEUCTR2004-005164-25-DKOdense University Hospital40